Your browser doesn't support javascript.
loading
GFI1B acts as a metabolic regulator in hematopoiesis and acute myeloid leukemia.
Liu, Longlong; Patnana, Pradeep Kumar; Xie, Xiaoqing; Frank, Daria; Nimmagadda, Subbaiah Chary; Su, Minhua; Zhang, Donghua; Koenig, Thorsten; Rosenbauer, Frank; Liebmann, Marie; Klotz, Luisa; Xu, Wendan; Vorwerk, Jan; Neumann, Felix; Hüve, Jana; Unger, Andreas; Okun, Jürgen Günther; Opalka, Bertram; Khandanpour, Cyrus.
Afiliação
  • Liu L; Department of Medicine A, Hematology, Oncology and Pneumology, University Hospital Muenster, 48149, Muenster, Germany.
  • Patnana PK; Department of Medicine A, Hematology, Oncology and Pneumology, University Hospital Muenster, 48149, Muenster, Germany.
  • Xie X; Department of Hematology and Stem Cell Transplantation, University Hospital Essen, University of Duisburg-Essen, 45147, Essen, Germany.
  • Frank D; Department of Medicine A, Hematology, Oncology and Pneumology, University Hospital Muenster, 48149, Muenster, Germany.
  • Nimmagadda SC; Department of Medicine A, Hematology, Oncology and Pneumology, University Hospital Muenster, 48149, Muenster, Germany.
  • Su M; Department of Hematology and Stem Cell Transplantation, University Hospital Essen, University of Duisburg-Essen, 45147, Essen, Germany.
  • Zhang D; Department of Medicine A, Hematology, Oncology and Pneumology, University Hospital Muenster, 48149, Muenster, Germany.
  • Koenig T; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, 300052, Tianjin, China.
  • Rosenbauer F; Department of Hematology, Tongji Hospital of Tongji Medical College of Huazhong University of Science and Technology, 430030, Wuhan, China.
  • Liebmann M; Institute of Molecular Tumor Biology, Faculty of Medicine, University of Muenster, 48149, Muenster, Germany.
  • Klotz L; Institute of Molecular Tumor Biology, Faculty of Medicine, University of Muenster, 48149, Muenster, Germany.
  • Xu W; Department of Neurology with Institute of Translational Neurology, University Hospital Muenster, 48149, Muenster, Germany.
  • Vorwerk J; Department of Neurology with Institute of Translational Neurology, University Hospital Muenster, 48149, Muenster, Germany.
  • Neumann F; Department of Medicine A, Hematology, Oncology and Pneumology, University Hospital Muenster, 48149, Muenster, Germany.
  • Hüve J; Department of Medicine A, Hematology, Oncology and Pneumology, University Hospital Muenster, 48149, Muenster, Germany.
  • Unger A; Fluorescence Microscopy Facility Muenster (FM)2, Institute of Medical Physics and Biophysics, University of Muenster, 48149, Muenster, Germany.
  • Okun JG; evorion biotechnologies GmbH, 48149, Muenster, Germany.
  • Opalka B; Fluorescence Microscopy Facility Muenster (FM)2, Institute of Medical Physics and Biophysics, University of Muenster, 48149, Muenster, Germany.
  • Khandanpour C; Institute of Physiology II, University of Muenster, 48149, Muenster, Germany.
Leukemia ; 36(9): 2196-2207, 2022 09.
Article em En | MEDLINE | ID: mdl-35804097
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteínas Repressoras / Leucemia Mieloide Aguda / Proteínas Proto-Oncogênicas / Hematopoese Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteínas Repressoras / Leucemia Mieloide Aguda / Proteínas Proto-Oncogênicas / Hematopoese Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article